金河生物
(002688)
| 流通市值：55.87亿 | | | 总市值：57.49亿 |
| 流通股本：7.50亿 | | | 总股本：7.72亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 625,272,499.32 | 616,526,916.58 | 635,892,867.63 | 841,385,051.31 |
| 应收票据及应收账款 | 667,406,425.44 | 622,667,353.5 | 578,522,930.73 | 542,122,190.92 |
| 其中：应收票据 | 77,110,569.66 | 79,287,768.6 | 79,911,276.81 | 89,145,771.92 |
| 应收账款 | 590,295,855.78 | 543,379,584.9 | 498,611,653.92 | 452,976,419 |
| 应收款项融资 | 69,195,768.68 | 78,617,101.43 | 81,373,923.29 | 85,251,117.69 |
| 预付款项 | 35,603,809.91 | 46,007,321.86 | 17,722,353.46 | 26,523,242.08 |
| 其他应收款合计 | 32,272,921.71 | 26,154,176.79 | 13,014,917.42 | 72,825,200 |
| 存货 | 679,736,654.36 | 666,182,132.79 | 635,279,943.82 | 619,563,756.4 |
| 其他流动资产 | 48,760,438.38 | 44,224,812.51 | 58,337,810.33 | 47,727,648.73 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,159,367,413.25 | 2,100,904,522.71 | 2,020,697,867.68 | 2,235,983,530.38 |
| 非流动资产: | | | | |
| 债权投资 | 5,179,604.16 | 5,091,258.33 | 5,003,883.33 | - |
| 长期股权投资 | 258,497.07 | 259,204.8 | 259,573.12 | 253,037.21 |
| 其他权益工具投资 | 11,900,000 | 11,900,000 | 11,900,000 | 11,900,000 |
| 固定资产 | 2,043,036,059.47 | 2,024,519,748.99 | 2,047,008,413.53 | 1,379,442,299.74 |
| 在建工程 | 224,408,757.43 | 228,264,373.19 | 246,272,790.76 | 707,659,076.08 |
| 使用权资产 | 28,564,031.48 | 28,381,239.82 | 28,847,533.15 | 39,649,102.88 |
| 无形资产 | 650,304,794.51 | 629,476,687.96 | 639,944,398.8 | 630,509,827.4 |
| 开发支出 | 64,312,548.05 | 78,555,731.13 | 75,312,101.46 | 87,849,398.3 |
| 商誉 | 459,700,748.91 | 460,092,788.12 | 460,296,808.55 | 495,213,573.21 |
| 长期待摊费用 | 14,680,074.24 | 15,832,324.98 | 16,807,446.1 | 16,875,081.13 |
| 递延所得税资产 | 73,019,190.39 | 51,963,930.59 | 71,211,031.61 | 51,442,472.31 |
| 其他非流动资产 | 50,253,886.52 | 46,807,413.48 | 27,025,734.95 | 81,112,559.75 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,625,618,192.23 | 3,581,144,701.39 | 3,629,889,715.36 | 3,501,906,428.01 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,784,985,605.48 | 5,682,049,224.1 | 5,650,587,583.04 | 5,737,889,958.39 |
| 流动负债: | | | | |
| 短期借款 | 1,039,757,872.59 | 1,069,829,360.7 | 1,032,380,445.83 | 1,185,848,740.59 |
| 应付票据及应付账款 | 273,718,082.31 | 259,257,882.58 | 313,709,597.87 | 210,141,125.61 |
| 其中：应付票据 | 7,360,000 | 7,360,000 | 24,995,861.11 | 27,000,000 |
| 应付账款 | 266,358,082.31 | 251,897,882.58 | 288,713,736.76 | 183,141,125.61 |
| 预收款项 | - | 46,510 | 49,285.71 | 32,290.1 |
| 合同负债 | 20,160,116.94 | 20,341,495.54 | 17,905,852.55 | 20,326,045.52 |
| 应付职工薪酬 | 24,277,398.49 | 20,098,441.6 | 25,155,428.79 | 28,382,230.69 |
| 应交税费 | 30,045,832.68 | 33,321,982.99 | 25,886,843.95 | 8,603,490.15 |
| 其他应付款合计 | 131,672,467.3 | 122,506,799.05 | 126,359,452.35 | 127,555,229.64 |
| 其中:应付利息 | 90,854.16 | 66,091.66 | - | - |
| 一年内到期的非流动负债 | 496,146,638.82 | 390,589,936.56 | 301,194,333.94 | 270,005,485.49 |
| 其他流动负债 | 30,070,896.77 | 21,921,420.36 | 18,566,495.36 | 27,475,076.1 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,045,849,305.9 | 1,937,913,829.38 | 1,861,207,736.35 | 1,878,369,713.89 |
| 非流动负债: | | | | |
| 长期借款 | 859,550,442.16 | 867,550,370.24 | 965,794,222.62 | 958,577,124.01 |
| 租赁负债 | 19,786,260.84 | 19,434,962.3 | 19,572,949.14 | 26,708,666.93 |
| 长期应付款 | 132,736,397.62 | 152,623,532.15 | 135,067,739.9 | 200,876,944.45 |
| 递延收益 | 54,606,943.61 | 54,665,896.35 | 56,115,463.03 | 50,347,027.8 |
| 递延所得税负债 | 97,273,360.39 | 91,809,264.72 | 112,966,702.18 | 115,299,911.03 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,163,953,404.62 | 1,186,084,025.76 | 1,289,517,076.87 | 1,351,809,674.22 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 3,209,802,710.52 | 3,123,997,855.14 | 3,150,724,813.22 | 3,230,179,388.11 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 771,634,398 | 771,694,398 | 771,694,398 | 771,694,398 |
| 资本公积 | 888,550,074.53 | 884,457,935.32 | 879,509,724.91 | 872,693,141.45 |
| 减:库存股 | 138,567,235.21 | 138,863,635.21 | 138,863,635.21 | 138,863,635.21 |
| 其他综合收益 | 15,615,169.14 | 17,058,254.73 | 17,774,614.34 | 5,344,122.09 |
| 专项储备 | 4,699,285.43 | 2,075,787.82 | 975,212.72 | 1,415,799.73 |
| 盈余公积 | 138,699,298.51 | 138,699,298.51 | 138,699,298.51 | 130,535,265.73 |
| 未分配利润 | 639,525,533.16 | 627,934,770.51 | 576,818,232.66 | 598,537,021.51 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,320,156,523.56 | 2,303,056,809.68 | 2,246,607,845.93 | 2,241,356,113.3 |
| 少数股东权益 | 255,026,371.4 | 254,994,559.28 | 253,254,923.89 | 266,354,456.98 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,575,182,894.96 | 2,558,051,368.96 | 2,499,862,769.82 | 2,507,710,570.28 |
| 负债和股东权益合计 | 5,784,985,605.48 | 5,682,049,224.1 | 5,650,587,583.04 | 5,737,889,958.39 |
| 公告日期 | 2025-07-31 | 2025-04-26 | 2025-04-26 | 2024-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |